April 13, 2009 |
About a year ago, patients began trooping into the office of UCLA psychiatrist Andrew Leuchter, asking whether an antipsychotic drug called Abilify "might be right for them." Few appeared to be delusional, plagued by hallucinations or suffering fearsome mood swings. Mostly, they were depressed or anxious, and frustrated by the pace of their recovery. Leuchter wondered what was up: Depressed patients didn't usually seek out drugs used to quell psychiatry's most disturbing symptoms.
December 14, 2008 |
'I need these pills refilled," the weary mother says, displaying an array of empty bottles on the desk in my office. "My son is bipolar." The boy, a quiet slip of a 10-year-old, had been prescribed two antipsychotics, two mood stabilizers, one antidepressant, two attention deficit disorder medications and another medication to manage the side effects of the antipsychotics. The mother explained that she had just regained custody of her son and his brother.
November 6, 2008 |
Sens. Charles E. Grassley (R-Iowa) and Herb Kohl (D-Wis.) have asked Johnson & Johnson to provide information about its payments to physicians as part of a widening investigation into drug makers' influence. The New Brunswick, N.J.-based company said the two powerful lawmakers were probing its ties to psychiatrists. Johnson & Johnson markets Risperdal, which is prescribed for schizophrenia and bipolar disorder. The senators also requested information about J&J's relationship with doctors who use its Cypher drug-coated stent to prop open arteries, according to a regulatory filing.
October 11, 2008 |
A study of 54 people with bipolar disorder found that the illness, long considered an adult affliction, also affects children. The research, published in Archives of General Psychology this week, said that 44% of those who had manic episodes as children continued having them as adults. "Children with mania grow into adults who have mania," said Dr. Barbara Geller of Washington University School of Medicine in St. Louis, who led the National Institutes of Health-funded study.
September 6, 2008 |
Children born to older fathers have a greater chance of developing bipolar disorder, according to one of the largest studies linking mental illness with advanced paternal age. The risks started increasing with fathers around age 40 but were strongest among those 55 and older, according to the study led by researchers at Sweden's Karolinska Institute.
September 6, 2007 |
Sales for children of antipsychotic medicines made by Johnson & Johnson, AstraZeneca and Pfizer Inc. have exploded, fueled by a fortyfold increase over nine years in the number of children diagnosed with bipolar disorder. The number of prescriptions for children doubled to 4.4 million from 2003 to 2006, according to data provided to Bloomberg by Wolters Kluwer, a drug-tracking company.
September 4, 2007 |
The diagnosis of bipolar disorder in children and adolescents has risen fortyfold since 1994, according to a study released Monday. But researchers partly attributed the dramatic rise to doctors over-diagnosing the serious psychiatric disorder. The report in the journal Archives of General Psychiatry said bipolar disorder was found in 1,003 of every 100,000 office visits from children and adolescents in 2002-03, compared with 25 of 100,000 office visits in 1994-95.
April 2, 2007
While we appreciate Jonathan Alpert's effort to assist people in making good choices about therapy [On the Mind: "In Therapy? Here's How to Assess Effectiveness," March 26], we think he has oversimplified the matter and offered something of a cookie-cutter approach. For example, not all modalities of therapy involve homework: psychoanalysis and psychodynamic treatment usually do not. Also, expecting results in a few weeks may make sense if one is experiencing mild anxiety or minor depression, but with chronic illnesses such as bipolar disorder, borderline personality or childhood post-traumatic stress disorder, more time is often necessary.
March 29, 2007 |
Antidepressants, which are widely prescribed with mood stabilizers to treat patients with bipolar disorder, do not work in relieving the depressive symptoms of the illness, a large federal study reported Wednesday. The study in the New England Journal of Medicine narrows the already limited number of treatments for bipolar disorder, which affects 5.7 million adults in the U.S., experts said. "A new generation of drugs is needed," said Dr. Thomas R.